Bradley, M., Markesbery, W., & Lovell, M. (2010). Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine, 48(12), 1570-6. https://doi.org/10.1016/j.freeradbiomed.2010.02.016 (Original work published 2010)

Bradley, M., Xiong-Fister, S., Markesbery, W., & Lovell, M. (2012). Elevated 4-hydroxyhexenal in Alzheimer’s disease (AD) progression. Neurobiology of Aging, 33(6), 1034-44. https://doi.org/10.1016/j.neurobiolaging.2010.08.016

Lovell, M., Xiong, S., Markesbery, W., & Lynn, B. (2005). Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochemical Research, 30(1), 113-22. https://doi.org/10.1007/s11064-004-9692-5

Lovell, M., Geiger, H., Van Zant, G., Lynn, B., & Markesbery, W. (2006). Isolation of neural precursor cells from Alzheimer’s disease and aged control postmortem brain. Neurobiology of Aging, 27(7), 909-17. https://doi.org/10.1016/j.neurobiolaging.2005.05.004

Williams, T., Lynn, B., Markesbery, W., & Lovell, M. (2006). Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer’s disease. Neurobiology of Aging, 27(8), 1094-9. https://doi.org/10.1016/j.neurobiolaging.2005.06.004

Lovell, M., Lynn, B., Xiong, S., Quinn, J., Kaye, J., & Markesbery, W. (2008). An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Neurology, 70(23), 2212-8. https://doi.org/10.1212/01.wnl.0000312383.39973.88 (Original work published 2008)

Lynn, B., Wang, J., Markesbery, W., & Lovell, M. Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer’s disease. Journal of Alzheimer’s Disease : JAD, 19(1), 325-39. https://doi.org/10.3233/JAD-2010-1254 (Original work published 2010)

Hensley, K., Butterfield, D., Hall, N., Cole, P., Subramaniam, R., Mark, R., … Aksenov, M. (1996). Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer’s disease-associated amyloid beta peptide. Annals of the New York Academy of Sciences, 786, 120-34. https://doi.org/10.1111/j.1749-6632.1996.tb39057.x (Original work published 1996)

Aksenov, M., Aksenova, M., Markesbery, W., & Butterfield, D. (1998). Amyloid beta-peptide (1-40)-mediated oxidative stress in cultured hippocampal neurons. Protein carbonyl formation, CK BB expression, and the level of Cu, Zn, and Mn SOD mRNA. Journal of Molecular Neuroscience : MN, 10(3), 181-92. https://doi.org/10.1007/BF02761773

Aksenova, M., Aksenov, M., Payne, R., Trojanowski, J., Schmidt, M., Carney, J., … Markesbery, W. (1969). Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobe in different neurodegenerative disorders. Dementia and Geriatric Cognitive Disorders, 10(2), 158-65. https://doi.org/10.1159/000017098 (Original work published 1969)